Michelson Prizes

April 12, 2023

The Michelson Prizes: Next Generation Grants are annual awards of $150,000which support early-career investigators who are working to significantly advance human immunology and vaccine and immunotherapy research for major global diseases.  The Prizes are awarded by the Michelson Medical Research Foundation and the Human Immunome Project (previously the Human Vaccines Project) —  applications are being accepted from 3 April 3 till 11 June 2023. Additional info can be found here.

  • About the Prizes: We are looking for research aimed at tackling the current roadblocks that exist in human vaccine development and expanding our limited understanding of key immune processes that are fundamental to successful vaccine and immunotherapy development. 
  • Eligibility: Researchers / scientists who are 35 and under.
  • Disciplines: Applicants from the full spectrum of immunology-related disciplines, including clinical research, biochemistry, molecular biology, protein engineering, computer science, artificial intelligence/machine learning, biophysics, environmental health, nanotechnology, etc., are encouraged to apply.  
  • Deadline:  11 June 2023

More News

Scholarships to Attend 21st Spring School on Immunology

October 10, 2025Deutsche Gesellschaft für Immunologie

IUIS 2025 Congress Recordings Now Available on ImmunoHub

September 30, 2025

Highlights from our Junior Community Scientific Symposium

September 26, 2025Early Career Committee (ECC), European Federation of Immunological Societies (EFIS) and 1 more

Opportunities from the International Science Council (ISC)

September 24, 2025

Funding Opportunity: ICLAS invites its members to apply for financial support

September 19, 2025Veterinary Immunology Committee (VIC)

IUIS 2025 Congress Recordings – Coming Soon on Immunohub!

September 9, 2025

IUIS Education Committee Brings You a Symposium

August 8, 2025Education Committee (EDU)

Visit the IUIS Booth at the IUIS 2025 Congress!

July 29, 2025

A message from IUIS President, Dr Miriam Merad

July 2, 2025